Login

Imuran Powder for Solution for Injection or Infusion 50mg

*
Pharmacy Only: Prescription

  • Company:

    Aspen

  • Status:

    No Recent Update

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

  • Active Ingredient(s):

    Azathioprine Sodium

    *Additional information is available within the SPC or upon request to the company

Updated on 07 November 2023

File name

Azat_Inj_IE_S_50mg_v9.pdf

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 07 November 2023

File name

Azat_Inj_IE_S_50mg_v9.pdf

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 11 October 2023

File name

Azat_Inj_IE_P_50mg-ml_v8.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - excipient warnings
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 31 January 2023

File name

Azat_Inj_IE_S_50mg_v8.pdf

Reasons for updating

  • Document format updated

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 10 September 2021

File name

Azat_Inj_IE_S_50mg_v8.pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 10 September 2021

File name

Azat_Inj_IE_P_50mg_v7.pdf

Reasons for updating

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 24 December 2019

File name

Azat_Inj_IE_S_50mg_v7.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 24 December 2019

File name

Azat_Inj_IE_P_50mg_v6.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Updated on 06 December 2019

File name

Azat_Tab_IE_S_50mg_v7.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 18 December 2018

File name

Azat_Inj_IE_P_50mg_v5.pdf

Reasons for updating

  • Change to Section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - excipient warnings
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision
  • Improved presentation of PIL

Updated on 18 December 2018

File name

Azat_Inj_IE_S_50mg_v5.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 11 October 2017

File name

PIL_9858_666.pdf

Reasons for updating

  • New PIL for new product

Updated on 11 October 2017

Reasons for updating

  • Change to section 6 - date of revision
  • Change to section 2 - what you need to know - warnings and precautions

Updated on 03 May 2017

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 10 January 2017

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 07 April 2014

Reasons for updating

  • Change to date of revision
  • Change to MA holder contact details

Updated on 06 March 2013

Reasons for updating

  • Change to improve clarity and readability
  • Change due to user-testing of patient information

Updated on 24 October 2012

Reasons for updating

  • Correction of spelling/typing errors

Updated on 01 June 2011

Reasons for updating

  • Change to MA holder contact details

Updated on 03 May 2011

Reasons for updating

  • Change to marketing authorisation holder

Updated on 12 March 2010

Reasons for updating

  • Change to marketing authorisation holder

Updated on 31 January 2007

Reasons for updating

  • Change to side-effects

Updated on 04 August 2005

Reasons for updating

  • Improved electronic presentation

Updated on 25 May 2005

Reasons for updating

  • New PIL for medicines.ie